Genrix (shanghai) Biopharmaceutical Co., Ltd.

This study tests whether a new drug called GR1803 works better than the standard combination of daratumumab, pomalidomide, and dexamethasone (DPd) for people with multiple myeloma that has returned or stopped responding after 1 to 3 prior treatments. About 358 adults will be rand…

This study tests a new medicine called GR1803 for people with systemic lupus erythematosus (SLE), an autoimmune disease where the body attacks itself. The trial will check if the drug is safe and if it helps control lupus symptoms. About 44 adults with active lupus who are alread…

This study tests an injection called GR1802 for people with seasonal allergies (hay fever) that are not well controlled by standard treatments. About 150 adults will receive either the drug or a placebo, along with their usual allergy medications. The goal is to see if the inject…

This early-stage study is testing a new drug, GR2303, in 64 healthy adults to see if it is safe and how the body handles it. Participants will receive either the drug or a placebo, and researchers will monitor for side effects and measure drug levels in the blood. This study does…